Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.
| Revenue (Most Recent Fiscal Year) | $573.28M |
| Net Income (Most Recent Fiscal Year) | $-33.54M |
| PE Ratio (Current Year Earnings Estimate) | 14.41 |
| PE Ratio (Trailing 12 Months) | 20.23 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.36 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.18 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.89 |
| Pre-Tax Margin (Trailing 12 Months) | -8.57% |
| Net Margin (Trailing 12 Months) | -5.85% |
| Return on Equity (Trailing 12 Months) | 19.67% |
| Return on Assets (Trailing 12 Months) | 4.97% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.31 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.87 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 1.66 |
| Inventory Turnover (Trailing 12 Months) | 2.02 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.28 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.15 |
| Earnings per Share (Most Recent Fiscal Year) | $0.49 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.51 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 81.94M |
| Free Float | 54.98M |
| Market Capitalization | $779.28M |
| Average Volume (Last 20 Days) | 0.41M |
| Beta (Past 60 Months) | 0.92 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 32.90% |
| Percentage Held By Institutions (Latest 13F Reports) | 62.94% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |